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Mennes 1 first noted that the serum of animals immunized against
pneumococci contains substances that favor phagocytosis of virulent
pneumococci. W right and Douglas 2 described as opsonins substances
in normal serum that attach themselves to bacteria and prepare them
for phagocytosis. Neufeld 3 showed that immune serum may alter
bacteria so that they become susceptible to phagocytosis, and he called
the substances responsible for this change bacteriotropins. Accord-
ing to Hektocn,' there appears to be no fundamental difference between
opsonins and bacteriotropins; normal serum contains a variety of
opsonic substances each of which is specific for a given bacterium, and
in immune serum the specific opsonic substance for the particular bac-
terium or cell with which immunization has been produced is developed
in a high degree; in both cases the full effect is produced by the inter-
action of two substances, one of which is destroyed by heating, while
the other remains unaffected; the latter is opsonic in itself but its
action is enhanced by the heat sensitive element, and it is the heat
resistant element that is produced specifically by experimental immuni-
zation or as the outcome of spontaneous infection. Clough 5 found
that soon after the crisis in pneumonia and also after lysis, the serum
may be actively opsonic for highly virulent homologous pneumococcus.
He states 6 that when the serum of patients recovering from pneumonia
"became inactive or feeble as a result of overheating or dilution, the
phagocytic activity could not be restored or increased by the addition
of complement."
The purpose of my experiments was to study once more the opsonic
activity of antipneumococcus serum with special reference to this prob-
lem of reactivation.
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The pneumococci used in the experiments were obtained from the
Army Medical School. The types 1, 2 and 3 strains are virulent, about
one ten millionth c c of an 18-hour broth culture killing mice within
48 hours. The type 4 strain (74), also from the Army Medical School,
was derived from a case of influenza pneumonia. The cultures were
transferred on blood-agar slants every third or fourth day. For the
experiments a 24-hour growth in 0.2% glucose broth was used.
Antipneumococcus serum of types 1, 2 and 3 was also obtained
from the Army Medical School. The type 4 serum was the serum of
a rabbit immunized against strain 74. Serum from six cases of lobar
pneumonia was studied also, blood being drawn from the vein at the
elbow 4-6 days after crisis. In one case (patient 2) blood was with-
drawn the first day after the crisis.
Human leukocytes were used: About 1 c c of blood was taken
from the lobe of the ear of a normal person and mixed with 2% solu-
tion of sodium citrate; after centrifugation and washing with 0.85%
salt solution, the leukocytic layer was removed and suspended in salt
solution. Fresh normal human serum was obtained in the usual way.
The opsonic activity of the serums was determined by mixing
serum, salt solution, leukocytes and bacterial suspension in capillary
pipets, which were incubated for 30 minutes at 37 C., smears made,
and stained with carbol thionin. The degree of phagocytosis was
estimated by counting the number of leukocytes per 100 that showed
phagocytosis and also the number of pneumococci ingested by each
leukocyte. In the activation experiments, the same process was fol-
lowed except that about 0.01 cc of the fresh (activating) serum was
added to the mixture, the amount of salt solution being reduced
accordingly.
Pneumococcus type 1 proved resistant to phagocytosis with fresh
normal human serum, the greatest number of leukocytes showing
phagocytosis in anyone specimen being 8 per 100 and the average num-
ber of bacteria in each phagocytic leukocyte being 2. Pneumococcus 2
also was resistant to phagocytosis with fresh normal human serum,
the greatest number of leukocytes showing phagocytosis in anyone
experiment being 3 in 100. Pneumococcus types 3 and 4 were more
readily phagocyted under the influence of fresh normal human serum
than the strains of types 1 and 2.
Antipneumococcus serums types 1,2 and 3 were found to have only
slight opsonic action on the homologous pneumococci, being even less
active than fresh normal human serum. This was particularly true of
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serum 3. Serum 4 was actively opsonic for pneumococcus 4. Although
the opsonic activity of serums 1, 2 and 3 was very slight, agglutination
occurred in all the preparations, and in pneumococci tended to group
themselves about the leukocytes.
The failure of the antipneumonic serum to opsonize homologous
pneumococci may be explained by the absence of the thermolabile,
complement-like element, and in that case the addition of fresh normal
human serum should result in an increase in phagocytosis of the pneu-
mococci. Accordingly, a number of activation experiments were made
and, as shown in table 1, a marked increase in the action of antipneu-
monic serum, type 1, for the homologous pneumococcus resulted after
the addition of a minute quantity of fresh normal serum. Serums 2
and 3 failed to show any increase in opsonic activity, after the addition
of fresh normal human serum; serum 4, while relatively active, was
distinctly enhanced in action by the addition of normal serum.
TABLE 1
REACTIVATION OF ANTIPNEUMOCOCCUS SERUM, TYPE 1
Results
Antlpneu- Pneumococci Leukocytic Normal Salt Percentage Number of
mococcus (Broth Suspen- Human Solu- of Pneumo-
Serum CUlture) sion Serum tion Phagocytic cocci per
Leuko- Active
evtes Phagocyte
0.1 0.1 0.1
-
0.1 8 2
0.1 0.1 0.1 O.ot 0.09 44 4
0.01 0.1 0.1 0.1 0.09 47 5
0.01 0.1 0.1 - 0.19 6 1
-
0.1 0.1 0.01 0.19 5 1
-
0.1 0.1 0.1 0.1 4 1
TABLE 2
REACTIVATION OF HEATED POSTCRITICAL PNEUMONIA SERUM FROM PATIENT 3
Results
Antipneu- Pneumococci Leukocytic Normal Salt Percentage Number of
mococcus (Broth Suspen- Human Solu- of Pneumo-
Serum Culture) slon Serum tlon Phagocytic cocci per
Leuko- Active
ertes Phagocyte
0.1 unheated 0.1 0.1 - 0.1 50 4
0.1 heated 0.1 0.1 - 0.1 1 4
0.1 heated 0.1 0.1 0.01 0.19 36 6
0.01heated 0.1 0.1 0.1 0.09 12 3
-
0.1 0.1 0.1 0.1 4 1
Pneumococcus, types 1 and 3 already described, were used to
determine the opsonic activity of serums of 6 pneumonia patients after
crisis. Of the 6 serums, 5 proved to be actively opsonic and agglutina-
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tive for pneumococcus type 1, but not for type 3. The serum of
patient 2 failed to cause phagocytosis of either type 1 or 3. The occur-
rence of such distinct agglutination and phagocytosis of pneumococcus
type 1 suggests that it concerned a type 1 infection in 5 of the cases.
The serums were heated for 30 minutes at 56 c., and the opsonic
power was greatly reduced thereby, but on the addition of a small
quantity of fresh normal serum to the heated serum, the opsonic
activity was restored almost to its original strength, as illustrated in
table 2.
SUMARY AND CONCLUSION
The results show that the opsonic power of the samples studied of
antipneumococcus serum of types 1 and 4 was increased by the addi-
tion of a minute quantity of fresh normal human serum; that serum
from 5 patients with lobar pneumonia after crisis was actively opsonic
for a pneumococcus strain of type 1, but lost this power in large mea-
sure on being heated to 56 c., regaining it, however, almost wholly by
the addition of small quantities of fresh normal human serum in itself
but feebly opsonic. The conclusion is that opsonin in antipneumococcus
serum can be reactivated.
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